Essentials of Medical Pharmacology (Covering Competency-Based NMC Curriculum)
Key Features
- Thoroughly updated chapters, incorporating new therapeutic approaches and recently marked drugs, such as long acting GLP-1 receptor agonists (Semaglutide) and SGLT-2 inhibitors (Dapagliflozin) for diabetes, neprilysin inhibitor (sacubitril) and SGLT-2 inhibitors for CHF, Orexin antagonists (Suvorexant) as hypnotic, Rho-Kinase inhibitor (Netarsudil) for glaucoma, adrenergic beta-3 agonist (Mirabegron) for overactive bladder, PCSK9 inhibitor (Inclisiran) as long acting hypocholesterolemic, CGRP receptor antagonists (Rimegepant) for migraine, PDE-4 inhibitor (Roflumilast) for COPD, and many others.
- Latest therapeutic and prophylactic regimens recommended under the National Health Programs for MDR/XDR-tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis, viral hepatitis, etc.
- Drugs and vaccines for COVID-19 and the latest AIIMS/ICMR guidelines for management of COVID.
- Pharmacovigilance program of India.
- Evidence based medicine with authenticated reference to latest therapeutic guidelines from WHO; ACC/AHA; ISH; NICE; SIGN; Cochrane reviews, meta analysis and landmark clinical trials.
- The WHO classification of antibiotics into `AWaRe” (Access, Watch, Reserve) groups.
- A Separate chapter on alcohols, drug dependence and drugs of abuse.
- A new chapter on environmental toxicology, poisonings; snake/dog bites and scorpion/bee stings.
- Chapterwise listing of abbreviations for user convenience.
- Several new figures, flow charts, tables and highlight boxes.
- Full coverage of competency-based pharmacology curriculum of NMC for graduate medical students.
Provides Additional Online/Digital Content
Dr Wise
Key Features
- Thoroughly updated chapters, incorporating new therapeutic approaches and recently marked drugs, such as long acting GLP-1 receptor agonists (Semaglutide) and SGLT-2 inhibitors (Dapagliflozin) for diabetes, neprilysin inhibitor (sacubitril) and SGLT-2 inhibitors for CHF, Orexin antagonists (Suvorexant) as hypnotic, Rho-Kinase inhibitor (Netarsudil) for glaucoma, adrenergic beta-3 agonist (Mirabegron) for overactive bladder, PCSK9 inhibitor (Inclisiran) as long acting hypocholesterolemic, CGRP receptor antagonists (Rimegepant) for migraine, PDE-4 inhibitor (Roflumilast) for COPD, and many others.
- Latest therapeutic and prophylactic regimens recommended under the National Health Programs for MDR/XDR-tuberculosis, leprosy, HIV, malaria, kala-azar, filariasis, viral hepatitis, etc.
- Drugs and vaccines for COVID-19 and the latest AIIMS/ICMR guidelines for management of COVID.
- Pharmacovigilance program of India.
- Evidence based medicine with authenticated reference to latest therapeutic guidelines from WHO; ACC/AHA; ISH; NICE; SIGN; Cochrane reviews, meta analysis and landmark clinical trials.
- The WHO classification of antibiotics into `AWaRe” (Access, Watch, Reserve) groups.
- A Separate chapter on alcohols, drug dependence and drugs of abuse.
- A new chapter on environmental toxicology, poisonings; snake/dog bites and scorpion/bee stings.
- Chapterwise listing of abbreviations for user convenience.
- Several new figures, flow charts, tables and highlight boxes.
- Full coverage of competency-based pharmacology curriculum of NMC for graduate medical students.
Provides Additional Online/Digital Content
Dr Wise
Description
Essential of Medical Pharmacology covers a wide range of topics from basic pharmacological concepts to practical therapeutics. Core pharmacodynamic, pharmacokinetic and dosage-form information about medicines is provided to understand mechanism of drug action and to enable rational selection of drugs for a patient and correct prescribing. This new edition is thoroughly revised for theoretical as well as clinical applications which are written in easy to learn language. In this new edition, more emphasis has been given on evidence-based pharmacology which is integrated with clinical medicine. National programmes are also included for the prevention and management of diseases are also included.
Product Details
Publisher :
JPB
Online Resources :
Complimentary online Drug Atlas & MCQs
Edition :
9/e
Binding :
Hard Back
Language :
English
Pages :
1144
ISBN-13 :
9789356962026
Item Weight :
2048 grams
Dimensions :
6.75 x 9.5
Printing Format Color :
Four Color
Copyright year :
2025
Chat Bot :
Dr.Wise AI Chatbot available